Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $101.53 million. The enterprise value is $95.52 million.

Market Cap	101.53M
Enterprise Value	95.52M

Important Dates

The next estimated earnings date is Thursday, May 16, 2024, before market open.

Earnings Date	May 16, 2024
Ex-Dividend Date	n/a

Share Statistics

Envoy Medical has 19.60 million shares outstanding. The number of shares has increased by 24.00% in one year.

Shares Outstanding	19.60M
Shares Change (YoY)	+24.00%
Shares Change (QoQ)	+11.93%
Owned by Insiders (%)	63.86%
Owned by Institutions (%)	16.25%
Float	6.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	313.85
Forward PS	262.79
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	302.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.03

Current Ratio	1.03
Quick Ratio	0.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-154.60%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$9,294
Profits Per Employee	-$879,647
Employee Count	34
Asset Turnover	0.02
Inventory Turnover	0.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.26% in the last 52 weeks. The beta is 1.24, so Envoy Medical's price volatility has been higher than the market average.

Beta (1Y)	1.24
52-Week Price Change	-50.26%
50-Day Moving Average	4.90
200-Day Moving Average	4.90
Relative Strength Index (RSI)	48.12
Average Volume (30 Days)	446,979

Short Selling Information

The latest short interest is 30,527, so 0.16% of the outstanding shares have been sold short.

Short Interest	30,527
Short Previous Month	42,534
Short % of Shares Out	0.16%
Short % of Float	0.44%
Short Ratio (days to cover)	0.19

Income Statement

In the last 12 months, Envoy Medical had revenue of $316,000 and -$29.91 million in losses. Loss per share was -$2.38.

Revenue	316,000
Gross Profit	-473,000
Operating Income	-18.37M
Pretax Income	-29.91M
Net Income	-29.91M
EBITDA	-29.78M
EBIT	-29.91M
Loss Per Share	-$2.38

Full Income Statement

Balance Sheet

The company has $4.22 million in cash and $562,000 in debt, giving a net cash position of $3.66 million or $0.19 per share.

Cash & Cash Equivalents	4.22M
Total Debt	562,000
Net Cash	3.66M
Net Cash Per Share	$0.19
Equity / Book Value	-1.76M
Book Value Per Share	-0.09
Working Capital	189,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.65 million and capital expenditures -$153,000, giving a free cash flow of -$17.81 million.

Operating Cash Flow	-17.65M
Capital Expenditures	-153,000
Free Cash Flow	-17.81M
FCF Per Share	-$1.42

Full Cash Flow Statement

Margins

Gross margin is -149.68%, with operating and profit margins of -5,813.61% and -9,464.56%.

Gross Margin	-149.68%
Operating Margin	-5,813.61%
Pretax Margin	-9,464.56%
Profit Margin	-9,464.56%
EBITDA Margin	-9,422.47%
EBIT Margin	-9,464.56%
FCF Margin	-5,635.13%

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.00%
Shareholder Yield	-24.00%
Earnings Yield	-30.16%
FCF Yield	-17.95%

Analyst Forecast

The average price target for Envoy Medical is $6.00, which is 15.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	15.83%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Envoy Medical has an Altman Z-Score of -53.66 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-53.66
Piotroski F-Score	4